Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-22

Clinical Trial Update: A Phase # Clinical Study Trial of Felbinac Trometamol Injection in China [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of Felbinac Trometamol Injection for pain in China has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Felbinac Trometamol Injection (Felbinac trometamol)

Snippet

Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd | Conditions: Pain | Phase 3 | Status: COMPLETED